CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Cash flows from operating activities:
Net income (loss)	$ 2,739,000	$ 69,000
Adjustments to reconcile net income (loss) to net cash:
Stock compensation expense	89,000	119,000
Foreign exchange loss (gain)	41,000	26,000
Depreciation and amortization	311,000	325,000
Deferred income taxes	(2,730,000)	(24,000)
Provision for inventory reserves	(3,000)	6,000
Other	76,000	34,000
Other changes in assets and liabilities:
Accounts receivable, net	(374,000)	(1,101,000)
Inventories	(280,000)	(218,000)
Costs in excess of billings and unbilled receivables	249,000	231,000
Prepaid expenses and other assets	189,000	(32,000)
Accounts payable	(99,000)	34,000
Accrued expenses and other liabilities	(790,000)	(303,000)
Deferred revenue	2,000	136,000
Net cash from operating activities	(580,000)	(698,000)
Cash flows from investing activities:
Purchases of property, plant and equipment	(111,000)	(603,000)
Net cash from investing activities	(111,000)	(603,000)
Cash flows from financing activities:
Proceeds from issuance of common stock	4,000	4,000
Net proceeds from issuance of convertible notes	0	390,000
Principal payments on capital leases	(28,000)	(46,000)
Proceeds from (payments of) line of credit, net	0	798,000
Proceeds from (payments of) bank and subordinated debt, net	(219,000)	(25,000)
Net cash from financing activities	(243,000)	1,121,000
Effect of exchange rates on cash and cash equivalents	(49,000)	(14,000)
Net change in cash and cash equivalents	(983,000)	(194,000)
Cash and cash equivalents, beginning	2,607,000	1,295,000
Cash and cash equivalents, ending	1,624,000	1,101,000
Non cash activities:
Assets purchased under capital leases	0	134,000
Recapitalization of Xcede - conversion of non controlling notes payable to preferred stock	3,104,000	0
Subsidiary stock options issued to settle liabilities	82,000	0
Subsidiary debt issued to fund research activities	$ 500,000	$ 0